V5 Ultimate
Ultimate
PricingResourcesCompany
Start free trial
HomeGlossaryPp / Ppk
Quality · The complete guide

Pp / PpkProcess Performance Index

In short

Pp and Ppk are the long-term process performance indices — calculated from the overall standard deviation across all batches in a reporting window, rather than the within-subgroup standard deviation used by Cp/Cpk. Pp/Ppk is the index FDA's Stage-3 Continued Process Verification guidance, ICH Q10 and Annual Product Review/PQR programmes expect on every commercial product.

3,300 words · ~15 min read
On this page
  1. 01What Pp and Ppk measure
  2. 02Formulas
  3. 03Interpreting Pp/Ppk values
  4. 04The Cpk-minus-Ppk gap
  5. 05Pairing Pp/Ppk with control-chart rules
  6. 06Sample size and the right window
  7. 07Common Pp/Ppk findings
  8. 08How V5 Ultimate calculates Pp/Ppk
On this page · 8 sections
  1. 1What Pp and Ppk measure
  2. 2Formulas
  3. 3Interpreting Pp/Ppk values
  4. 4The Cpk-minus-Ppk gap
  5. 5Pairing Pp/Ppk with control-chart rules
  6. 6Sample size and the right window
  7. 7Common Pp/Ppk findings
  8. 8How V5 Ultimate calculates Pp/Ppk
AI · Explain it for MY operation

How does Pp / Ppk apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01What Pp and Ppk measure

Pp and Ppk answer the question 'over the last reporting period — typically rolling 12 months or 25 batches — has this process actually delivered product within specification with adequate margin?'. They differ from Cp/Cpk in one variable: the standard-deviation estimate. Cp/Cpk uses σ_within (the within-subgroup standard deviation, estimated from R-bar / d2 or s-bar / c4), which captures only common-cause variation inside a single batch / shift / subgroup. Pp/Ppk uses σ_overall (the sample standard deviation across all measurements in the window), which captures common-cause AND between-batch variation — operator change, supplier-lot change, season, equipment drift. σ_overall is almost always larger than σ_within; therefore Pp ≤ Cp and Ppk ≤ Cpk for the same process. The gap is itself diagnostic.

One-sentence summary

Cp/Cpk tells you how good the process can be on its best day; Pp/Ppk tells you how good it actually was last year.

02Formulas

  • Pp = (USL − LSL) / (6 × σ_overall)
  • Ppu = (USL − mean) / (3 × σ_overall)
  • Ppl = (mean − LSL) / (3 × σ_overall)
  • Ppk = min(Ppu, Ppl)
  • σ_overall = √( Σ(xi − x̄)² / (n − 1) ) — pooled across every observation in the window.

Ppm (Process Performance Mean) — Ppk corrected for off-target operation, analogous to Cpm. Less commonly reported but valuable when target is the explicit aim (e.g. dose accuracy at 100% of label claim).

03Interpreting Pp/Ppk values

  • Ppk ≥ 1.67 — process performing comfortably above 6σ; commonly required for CQAs in commercial pharma.
  • Ppk 1.33-1.67 — adequate but watch trends; FDA's commonly-cited capability target sits in this band.
  • Ppk 1.00-1.33 — acceptable but variable; investigate sources of between-batch variation.
  • Ppk < 1.00 — process is producing out-of-spec material at a rate of >2,700 ppm; an OOS event is statistically likely soon.
  • Ppk negative — process mean is outside the spec; immediate intervention required.

04The Cpk-minus-Ppk gap

If Cpk is materially better than Ppk (say Cpk = 1.5 but Ppk = 1.0), the process is capable within a batch but drifting between batches. Diagnostically this points to assignable causes outside the subgroup definition: incoming-material lot variation, environmental drift (humidity, season), operator skill differences across shifts, calibration drift, equipment wear. The Cpk-Ppk gap is one of the first signals examined in a Stage-3 CPV review and the most useful single number for prioritising continuous-improvement effort. If Cpk ≈ Ppk the process is homogeneous over time — closing it tighter requires reducing common-cause variation (DoE, equipment upgrade, supplier consolidation).

The trap

Reporting Cpk only and ignoring Ppk hides between-batch drift. A process can have Cpk 1.8 and Ppk 0.9 — beautiful inside each batch and chronically variable across them. Stage-3 CPV reviewers ask for both.

05Pairing Pp/Ppk with control-chart rules

A single Pp/Ppk number per quarter is necessary but insufficient — it tells you the historical capability of the window, but not whether the process is changing inside the window. The standard pairing is a rolling Pp/Ppk plus a control chart of subgroup means with Western Electric / Nelson out-of-trend rules: a point beyond 3σ, two of three beyond 2σ, four of five beyond 1σ, eight in a row on one side of the centerline, six trending, fourteen alternating, etc. The chart signals shifts and trends; the Pp/Ppk number quantifies the resulting margin to spec.

06Sample size and the right window

Pp/Ppk is statistically unstable below ~25 data points and unreliable below ~10. Stage-3 CPV programmes typically wait until 25 commercial batches have been made before reporting Pp/Ppk with confidence; before that they report individual-value charts and lot-by-lot pass/fail. The reporting window itself is a deliberate choice — too short and the index is noisy; too long and it averages over distinct process states (pre/post a change-control, pre/post a supplier change). A 12-month rolling window with a CUSUM or change-point analysis is a common middle ground.

07Common Pp/Ppk findings

  1. Reporting Cpk in the APR but calling it Ppk — same letter swap, fundamentally different number.
  2. Using a long window that spans a process change, washing out the very improvement the change was supposed to deliver.
  3. Calculating Ppk on a non-normally-distributed attribute without transformation — Box-Cox or distribution-fit first, then index.
  4. Ignoring one-sided spec attributes (e.g. assay ≥ 95%) — report Ppk against the one-sided limit, not a fake LSL.
  5. Using Ppk to argue 'capability proven' without a parallel SPC chart — index is high because the average is on-target but the chart shows a clear up-drift.
  6. Mid-window outlier (a lab error, a re-tested sample, a real OOS) included or excluded inconsistently — the rule must be pre-defined.

08How V5 Ultimate calculates Pp/Ppk

  • Per-CQA rolling Pp/Ppk and Cp/Cpk shown side by side on the Stage-3 dashboard — the gap is highlighted automatically.
  • Configurable window (rolling 12 months / 25 batches / since-last-change-control) — change-control IDs are visible on the chart so the analyst can see the process state.
  • Western Electric and Nelson out-of-trend rules running in real time; a violation opens a Stage-3 investigation with all the lot context attached.
  • Distribution-fit check (Anderson-Darling, Shapiro-Wilk) flagged before reporting Ppk — non-normal attributes are transformed or analysed by percentile.
  • One-sided spec handling — Ppk against the relevant limit, not a synthetic LSL.
  • APR / PQR consumes the rolling Pp/Ppk per CQA — the annual review and the live dashboard agree by construction.
The honest version

V5 will not interpret your trends for you — that's qualified Stage-3 review work. What V5 does is calculate the numbers correctly, surface the Cpk-Ppk gap and the Nelson signals at the moment they happen, and remove the spreadsheet-archaeology step from your APR.

Frequently asked questions

Q.Which index does FDA actually expect — Cpk or Ppk?+

Both. PPQ (Stage 2) typically reports Cpk on the qualifying batches because there are only three and the within-subgroup estimate is the cleaner number; commercial CPV (Stage 3) reports Ppk on the rolling window because between-batch variation is the dominant source. The 2011 PV guidance does not mandate a specific index; the 2024 revision clarifies that the lifecycle should report both.

Q.Is a high Ppk enough to skip release testing?+

No. Demonstrated long-term capability is a prerequisite for Real-Time Release Testing (RTRT) under ICH Q8/Q12, but RTRT also requires PAT-grade in-process measurement and regulatory approval of the control strategy. High Ppk supports the business case for RTRT; it doesn't authorise skipping release on its own.

Q.Should we report Ppk per batch or per process?+

Per CQA per process per reporting window. A batch is too small a sample for a meaningful index; an aggregate across products hides the per-product performance. Most APR/PQR programmes report one rolling Ppk per CQA per product per site per year.

Q.What if the data is non-normal?+

Run a normality test first. If non-normal: transform (Box-Cox is the standard choice), refit, then calculate Ppk on the transformed scale and back-transform for interpretation. Alternatively use a percentile-based capability index (Clements method or the empirical 0.135%-99.865% percentile range). Reporting Ppk on visibly non-normal data without acknowledging the issue is a common observation.

Q.How is Ppk related to ppm defective?+

For normally distributed data, Ppk corresponds to a tail probability: Ppk = 1.00 → ~2,700 ppm out of spec (both tails); Ppk = 1.33 → ~63 ppm; Ppk = 1.67 → ~0.6 ppm; Ppk = 2.00 → ~0.002 ppm (the 6-sigma target). For non-normal data the correspondence breaks and per-tail empirical estimates are more honest.

Primary sources

  • FDA Guidance: Process Validation — General Principles and Practices (2011, rev. 2024)
  • ICH Q10 Pharmaceutical Quality System
  • AIAG SPC Reference Manual (2nd ed., 2005)
  • Montgomery, Introduction to Statistical Quality Control (8th ed.)
  • Western Electric Statistical Quality Control Handbook (1956)

Further reading

  • Cp / Cpk
    Short-term within-subgroup capability.
  • CPV
    Stage-3 lifecycle programme that uses Pp/Ppk.
  • SPC
    Control-chart spine under both.
  • APR / PQR
    Annual review consumes rolling Pp/Ppk.
  • Process validation
    Stage 2 PPQ → Stage 3 Pp/Ppk.
Software that covers Pp / Ppk
V5 Ultimate Quality Control Software
In-process checks, sampling plans, spec limits, SPC trending, CoA generation and hold/release — enforced at the kiosk while the…

Explore this topic

Pp / Ppk sits inside this topic cluster in our glossary. Every neighbour is one click away.

Quality tools & investigation
26 related entries

Root-cause toolkit, SPC, capability and the rest of the QA practitioner's bench.

CAPANCRDeviationOOSOOTRoot cause analysis5 Whys8DFMEAFishbone / IshikawaRisk matrixSPCCp / CpkMSAGage R&RAQLRFTFPYYield ReconciliationSMEDOEEAudit managementISO auditCustomer complaintSupplier scorecardSupplier risk management
Talk to us about Pp / Ppk

Want to see how Pp / Ppk could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Inside V5
  • → Analytics — every number is a real signed event.
Related terms
  • → Cp / Cpk
  • → SPC
  • → CPV
  • → CAPA
  • → NCR
  • → Deviation
  • → OOS
  • → OOT
  • → Root cause analysis
  • → 5 Whys
  • → 8D
  • → FMEA
  • → Fishbone / Ishikawa
  • → Risk matrix
  • → MSA
  • → Gage R&R
  • → AQL

Next step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse all features
V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal centre

© V5 Ultimate